Targeted disruption of Plasmodium falciparum cysteine protease, falcipain 1, reduces oocyst production, not erythrocytic stage growth

Abstract excerpt

Cysteine proteases are currently targets for drug development in a number of parasitic diseases, including malaria. In Plasmodium falciparum, the parasite responsible for the most virulent form of human malaria, there are four members of the cathepsin L-like family of cysteine proteases. Three of these (falcipains 2A, 2B and 3) are thought to be primarily involved in haemoglobin digestion, whereas falcipain 1 has...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Insect Resistance and Genetics
• Share to Invertebrate Immune Response Mechanisms
• Share to Malaria Research and Control